Chargement en cours...
Acute myeloid leukemia and NK cells: two warriors confront each other
Acute myeloid leukemia (AML) is a heterogeneous disease whose therapies currently show elevated toxicity and a high rate of relapse. Recently, the burgeoning of new anti-tumor therapeutic strategies aimed at enhancing the immune response has pushed natural killer cells (NKs) into the spotlight. Thes...
Enregistré dans:
| Publié dans: | Oncoimmunology |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343801/ https://ncbi.nlm.nih.gov/pubmed/30713800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1539617 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|